Skyline Therapeutics
Developing innovative treatments for genetic diseases through gene therapy.
Developing innovative treatments for genetic diseases through gene therapy.
Sector
Life SciencesCategory
TherapeuticsLocations
Hangzhou, ChinaShanghai, China
Initial Investment
2018Skyline Therapeutics (formerly Geneception) is a fully-integrated gene and cell therapy based in Hangzhou and Shanghai, China. Founded by F-Prime Capital, Eight Roads Ventures China and Lilly Asia Ventures in 2018, Skyline’s mission is to become a preeminent gene and cell therapy company, working to deliver world-class therapeutics for patients in China and globally.